LP
LJPC

LMR Partners’s La Jolla Pharmaceutical Company LJPC Stock Holding History

LMR Partners’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,515
Closed -$49K – 1360
2021
Q2 		$49K Buy
+11,515
New +$49.3K ﹤0.01% 992
2017
Q3 		– Sell
-18,083
Closed -$538K – 698
2017
Q2 		$538K Sell
18,083
-61,917
-77% -$1.77M 0.03% 404
2017
Q1 		$2.39M Buy
+80,000
New +$2.04M 0.23% 72

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return

LMR Partners's LJPC Position: Q3 2021 in Review

LMR Partners sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2021, closing a stake of 11,515 shares — an estimated $49K sold.

LMR Partners first reported a position in LJPC in Q1 2017 and held it in 3 quarters. The position peaked at $2.39M in Q1 2017. 54 funds tracked by Wall St. Rank hold LJPC as of Q3 2021.

  • LMR Partners reported no remaining La Jolla Pharmaceutical Company position as of Q3 2021 after selling out during the quarter.
  • LMR Partners sold 11,515 La Jolla Pharmaceutical Company shares in Q3 2021, an estimated $49K.
  • LMR Partners first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and held it in 3 quarters.
  • LMR Partners's La Jolla Pharmaceutical Company position peaked at $2.39M in Q1 2017.
  • 54 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2021.

Based on LMR Partners's 13F filing for Q3 2021, filed 15 Nov 2021.